Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by mbanxon Mar 11, 2020 6:30pm
232 Views
Post# 30796001

FP says Aurora at risk of being delisted from NYSE

FP says Aurora at risk of being delisted from NYSE

2020-03-11 08:15 ET - In the News

Also In the News (C-WEED) Canopy Growth Corp

The Financial Post reports in its Wednesday, March 11, edition that the pace of making deals in the already embattled cannabis sector is expected to slow even further. The Post's Vanmala Subramaniam writes that Stoic Advisory analyst Aaron Salz says: "Obviously when you have this level of macro pullback, it always affects risky industries like cannabis the most. I'm seeing it in real time for sure. Groups that were prepared to jump in on deals, have walked away for the time being. It's risk-off right now." Canopy Growth has lost more than 30 per cent in the past two weeks, and Aurora Cannabis, which has been struggling with a severe cash-flow issue, saw its stock decline by 40 per cent in the same period, and is priced such that it is at risk of being delisted from the New York Stock Exchange. Canaccord analyst Matt Bottomley says: "I don't think you're going to see M& A activity for the sake of it, just because companies are cheaper. There is too much growing capacity right now, so it does not make sense for everyone to start combining and merging." He says there are just too many companies that are not cash- low positive, so there is little appetite to want to get involved in them.

Bullboard Posts